StockData

TFA Therapeutics, Inc. (RAJAF) stock

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

TFA Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

TFA Therapeutics's profit margin for the twelve months ending Dec 31, 2023 was 85.2%. For fiscal 2025 it was -12.4%, against -18.1% the year before. The highest annual figure on record is 85.2% in fiscal 2023.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-12.4%+5.6
FY2024Dec 31, 2024-18.1%−103.2
FY2023Dec 31, 202385.2%+1436.1
FY2022Dec 31, 2022-1350.9%−1295.1
FY2021Dec 31, 2021-55.8%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2023Dec 31, 2023285.6%–

More TFA Therapeutics figures

See a number that looks wrong?